{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T15:58:26Z","timestamp":1772207906904,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T00:00:00Z","timestamp":1764633600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Medical Science Research Project of Hebei","award":["20240273"],"award-info":[{"award-number":["20240273"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s43032-025-02013-3","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T16:44:33Z","timestamp":1764693873000},"page":"94-104","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The Role of Four New Biochemical Markers in the Diagnosis and Prognosis of Ovarian Carcinoma"],"prefix":"10.1007","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7639-4024","authenticated-orcid":false,"given":"Yanan","family":"Ren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2770-3836","authenticated-orcid":false,"given":"Junqin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5000-7501","authenticated-orcid":false,"given":"Ren","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4371-0558","authenticated-orcid":false,"given":"Di","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0305-275X","authenticated-orcid":false,"given":"Jie","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4215-9346","authenticated-orcid":false,"given":"Qing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,12,2]]},"reference":[{"key":"2013_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22094305","author":"D Jiang","year":"2021","unstructured":"Jiang D, Wang F, Zhang H, Gao W, Tong X, Lv C, et al. Formation of proto-Kranz in C3 rice induced by spike-stalk injection method. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22094305.","journal-title":"Int J Mol Sci"},{"key":"2013_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.577869","volume":"11","author":"C Yang","year":"2020","unstructured":"Yang C, Xia BR, Zhang ZC, Zhang YJ, Lou G, Jin WL. Immunotherapy for ovarian cancer: adjuvant, combination, and neoadjuvant. Front Immunol. 2020;11:577869.","journal-title":"Front Immunol"},{"key":"2013_CR3","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12861-021-00245-5","volume":"21","author":"RR Khasawneh","year":"2021","unstructured":"Khasawneh RR, Kist R, Queen R, Hussain R, Coxhead J, Schneider JE, et al. Msx1 haploinsufficiency modifies the Pax9-deficient cardiovascular phenotype. BMC Dev Biol. 2021;21:14.","journal-title":"BMC Dev Biol"},{"key":"2013_CR4","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1177\/0022034518811861","volume":"98","author":"R Li","year":"2019","unstructured":"Li R, Chen Z, Yu Q, Weng M, Chen Z. The function and regulatory network of Pax9 gene in palate development. J Dent Res. 2019;98:277\u201387.","journal-title":"J Dent Res"},{"key":"2013_CR5","doi-asserted-by":"publisher","first-page":"4696","DOI":"10.1158\/0008-5472.CAN-21-1114","volume":"81","author":"Z Zhao","year":"2021","unstructured":"Zhao Z, Szczepanski AP, Tsuboyama N, Abdala-Valencia H, Goo YA. PAX9 determines epigenetic state transition and cell fate in cancer. Cancer Res. 2021;81:4696\u2013708.","journal-title":"Cancer Res"},{"key":"2013_CR6","first-page":"793","volume":"30","author":"H Li","year":"2022","unstructured":"Li H, Li Z, Sun X. Values of serum HK10 and PIVKA-\u2161 levels for diagnosing and predicting the prognosis of ovarian cancer. Chinese Journal of Family Planning. 2022;30:793\u20139.","journal-title":"Chinese Journal of Family Planning."},{"key":"2013_CR7","first-page":"45","volume":"20","author":"N Li","year":"2022","unstructured":"Li N, Xue H, Pei H. Expression and significance of serum human kallikrein 10, DJ-1, carbohydrate antigen 125, human epididymis protein 4 in patients with ovarian cancer. Oncology Progress. 2022;20:45\u20138.","journal-title":"Oncology Progress"},{"key":"2013_CR8","doi-asserted-by":"publisher","DOI":"10.1242\/dev.195651","author":"M Kaiser","year":"2021","unstructured":"Kaiser M, Wojahn I, Rudat C, L\u00fcdtke TH, Christoffels VM, Moon A, et al. Regulation of otocyst patterning by Tbx2 and Tbx3 is required for inner ear morphogenesis in the mouse. Development. 2021. https:\/\/doi.org\/10.1242\/dev.195651.","journal-title":"Development"},{"key":"2013_CR9","doi-asserted-by":"publisher","first-page":"388","DOI":"10.7150\/jca.31636","volume":"11","author":"H Yu","year":"2020","unstructured":"Yu H, Zhao F, Li J, Zhu K, Lin H, Pan Z, et al. TBX2 identified as a potential predictor of bone metastasis in lung adenocarcinoma via integrated bioinformatics analyses and verification of functional assay. J Cancer. 2020;11:388\u2013402.","journal-title":"J Cancer"},{"key":"2013_CR10","doi-asserted-by":"publisher","first-page":"5971","DOI":"10.1038\/s41388-019-0853-z","volume":"38","author":"NT Crawford","year":"2019","unstructured":"Crawford NT, McIntyre AJ, McCormick A, D\u2019Costa ZC, Buckley NE. TBX2 interacts with heterochromatin protein 1 to recruit a novel repression complex to EGR1-targeted promoters to drive the proliferation of breast cancer cells. Oncogene. 2019;38:5971\u201386.","journal-title":"Oncogene"},{"key":"2013_CR11","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/1724600819868234","volume":"34","author":"L Fu","year":"2019","unstructured":"Fu L, Wang R, Yin L. CYFRA21-1 tests in the diagnosis of non-small cell lung cancer: a meta-analysis. Int J Biol Markers. 2019;34:251\u201361.","journal-title":"Int J Biol Markers"},{"key":"2013_CR12","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12967-019-1828-0","volume":"17","author":"MG Dal Bello","year":"2019","unstructured":"Dal Bello MG, Filiberti RA, Alama A, Orengo AM, Mussap M, Coco S, et al. The role of CEA, CYFRA21-1 and NSE in monitoring tumor response to Nivolumab in advanced non-small cell lung cancer (NSCLC) patients. J Transl Med. 2019;17:74.","journal-title":"J Transl Med"},{"key":"2013_CR13","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1148\/rg.2020200013","volume":"40","author":"MY Salib","year":"2020","unstructured":"Salib MY, Russell JHB, Stewart VR. 2018 FIGO staging classification for cervical cancer: added benefits of imaging. Radiographics. 2020;40:1807\u201322.","journal-title":"Radiographics"},{"key":"2013_CR14","unstructured":"Ren Y. Expression and clinical significance of TBX2 and PAX9 in epithelial ovarian cancer: Hebei Medical University; 2014."},{"key":"2013_CR15","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1007\/s11912-020-0883-2","volume":"22","author":"P Benedetti Panici","year":"2020","unstructured":"Benedetti Panici P, Giannini A, Fischetti M, Lecce F, Di Donato V. Lymphadenectomy in ovarian cancer: is it still justified? Curr Oncol Rep. 2020;22:22.","journal-title":"Curr Oncol Rep"},{"key":"2013_CR16","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1007\/s10147-019-01536-5","volume":"25","author":"K Murakami","year":"2020","unstructured":"Murakami K, Kotani Y, Shiro R, Takaya H, Nakai H, Matsumura N. Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts. Int J Clin Oncol. 2020;25:51\u20138.","journal-title":"Int J Clin Oncol"},{"key":"2013_CR17","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1177\/1465312518820537","volume":"46","author":"MSA Devi","year":"2019","unstructured":"Devi MSA, Padmanabhan S. Role of polymorphisms of MSX1 and PAX9 genes in palatal impaction of maxillary canines. J Orthod. 2019;46:14\u20139.","journal-title":"J Orthod"},{"key":"2013_CR18","first-page":"207","volume":"56","author":"J Shi","year":"2021","unstructured":"Shi J, Jia L, Zhang X. Identification of a novel mutation of the PAX9 gene and clinical treatment in a nonsyndromic oligodontia family. Chin J Stomatol. 2021;56:207\u20139.","journal-title":"Chin J Stomatol"},{"key":"2013_CR19","first-page":"5","volume":"37","author":"S Zhu","year":"2016","unstructured":"Zhu S, Jia L, Zhang X. Expression of PAX9 in esophageal squamous cell carcinoma. J Liaoning Med Univ. 2016;37:5\u20138.","journal-title":"J Liaoning Med Univ"},{"key":"2013_CR20","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1186\/s13148-021-01149-8","volume":"13","author":"JA Soto","year":"2021","unstructured":"Soto JA, Rodr\u00edguez-Antol\u00edn C, Vera O, Pern\u00eda O, Esteban-Rodr\u00edguez I, Dolores Diestro M, et al. Transcriptional epigenetic regulation of Fkbp1\/Pax9 genes is associated with impaired sensitivity to platinum treatment in ovarian cancer. Clin Epigenetics. 2021;13:167.","journal-title":"Clin Epigenetics"},{"key":"2013_CR21","unstructured":"Zhang X, Wang Y, Huang R. Expression of hK10 in ovarian cancer tissue and its significances. Journal of Jilin University. 2008:661\u20134."},{"key":"2013_CR22","first-page":"178","volume":"31","author":"J Wang","year":"2015","unstructured":"Wang J, Zhang X, Chen L. Serum level of CA125 and hk10 in patients with ovarian cancer. Chin J Clin Pharmacol. 2015;31:178\u201380.","journal-title":"Chin J Clin Pharmacol"},{"key":"2013_CR23","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1101\/gad.348746.121","volume":"35","author":"S Lu","year":"2021","unstructured":"Lu S, Louphrasitthiphol P, Goradia N, Lambert JP, Schmidt J, Chauhan J, et al. TBX2 controls a proproliferative gene expression program in melanoma. Genes Dev. 2021;35:1657\u201377.","journal-title":"Genes Dev"},{"key":"2013_CR24","doi-asserted-by":"crossref","unstructured":"Patel GK, Dutta S, Syed MM, Ramachandran S, Sharma M, Rajamanickam V, et al. TBX2 Drives Neuroendocrine Prostate Cancer through Exosome-Mediated Repression of miR-200c-3p. 2021;13.","DOI":"10.3390\/cancers13195020"},{"key":"2013_CR25","first-page":"3085","volume":"15","author":"R Tasaka","year":"2018","unstructured":"Tasaka R, Fukuda T, Shimomura M, Inoue Y, Wada T, Kawanishi M, et al. TBX2 expression is associated with platinum-sensitivity of ovarian serous carcinoma. Oncol Lett. 2018;15:3085\u201390.","journal-title":"Oncol Lett"},{"key":"2013_CR26","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13048-019-0587-0","volume":"12","author":"C Jin","year":"2019","unstructured":"Jin C, Yang M, Han X, Chu H, Zhang Y, Lu M, et al. Evaluation of the value of preoperative CYFRA21-1 in the diagnosis and prognosis of epithelial ovarian cancer in conjunction with CA125. J Ovarian Res. 2019;12:114.","journal-title":"J Ovarian Res"},{"key":"2013_CR27","first-page":"85","volume":"38","author":"R Ma","year":"2017","unstructured":"Ma R, Liu J, Cheng J. Serum levels of human kallikrein 10, insulin-like growth factor-\u2160 and soluble mesothelin-related proteins in patients with ovarian cancer. Journal of Tongji University (Medical Science). 2017;38:85\u20139.","journal-title":"Journal of Tongji University (Medical Science)."},{"key":"2013_CR28","unstructured":"Gu Z. Exploration of the bidirectional mechanism of PAX9 in platinum-based resistance in epithelial ovarian cancer and its clinical significance: ShangHai Jiao Tong University; 2016."},{"key":"2013_CR29","first-page":"55","volume":"40","author":"X Lu","year":"2022","unstructured":"Lu X, Lin H, Huang Y. Effect of combined albumin-bound paclitaxel and nedaplatin on recurrent and metastatic cervical cancer and serum CYFRA21-1 and VEGF-C levels. J Guangdong Med Coll. 2022;40:55\u20138.","journal-title":"J Guangdong Med Coll"},{"key":"2013_CR30","first-page":"152","volume":"11","author":"M Lin","year":"2021","unstructured":"Lin M. The value of serum CA724, CYFRA21-1 and PIVKA-\u2161 in the diagnosis of ovarian cancer. China Medicine and Pharmacy. 2021;11:152\u20134.","journal-title":"China Medicine and Pharmacy"},{"key":"2013_CR31","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1186\/s12957-016-0866-9","volume":"14","author":"J Boone","year":"2016","unstructured":"Boone J, Hobbelink MG, Schipper ME, Vleggaar FP, Borel Rinkes IH, de Haas RJ, et al. Sentinel node biopsy during thoracolaparoscopic esophagectomy for advanced esophageal cancer. World J Surg Oncol. 2016;14:117.","journal-title":"World J Surg Oncol"},{"key":"2013_CR32","first-page":"16","volume":"59","author":"X Ren","year":"2019","unstructured":"Ren X, Li Y, Cheng G. Expression and significance of serum HK10 and DJ-1 in patients with ovarian cancer. Shandong Med J. 2019;59:16\u20139.","journal-title":"Shandong Med J"},{"key":"2013_CR33","first-page":"2344","volume":"18","author":"L Qian","year":"2021","unstructured":"Qian L. Clinical value of serum PIVKA-\u2161, AFP and CYFRA21-1 in patients with ovarian cancer. Laboratory Medicine and Clinic. 2021;18:2344\u20136.","journal-title":"Laboratory Medicine and Clinic"},{"key":"2013_CR34","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.ygyno.2024.12.011","volume":"193","author":"G Bogani","year":"2025","unstructured":"Bogani G, Moore KN, Ray-Coquard I, Lorusso D, Matulonis UA, Ledermann JA, et al. Incorporating immune checkpoint inhibitors in epithelial ovarian cancer. Gynecol Oncol. 2025;193:30\u201340.","journal-title":"Gynecol Oncol"}],"updated-by":[{"DOI":"10.1007\/s43032-025-02041-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T00:00:00Z","timestamp":1766361600000}}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-025-02013-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43032-025-02013-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43032-025-02013-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T14:57:51Z","timestamp":1772204271000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43032-025-02013-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,2]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["2013"],"URL":"https:\/\/doi.org\/10.1007\/s43032-025-02013-3","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,2]]},"assertion":[{"value":"19 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s43032-025-02041-z","URL":"https:\/\/doi.org\/10.1007\/s43032-025-02041-z","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The study protocol was approved by the Ethics Committee of Hebei General Hospital. Informed consent was obtained from all the study subjects before enrollment.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}